Alexandria Lauren Irace

Alexandria Lauren Irace

Auto-generated profile, based on publicly available information

Alexandria Lauren Irace

Department of Otorhinolaryngology – Head & Neck Surgery University of Pennsylvania Health System Philadelphia Pennsylvania USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2017 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
PVPriatharisiny Velayutham
Priatharisiny Velayutham
AIAlexandria L. Irace
Alexandria L. Irace
KKKosuke Kawai
Kosuke Kawai
PDPamela Dodrill
Pamela Dodrill
JPJennifer Perez
Jennifer Perez
RRReza Rahbar
Reza Rahbar

7 August 2017 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
JSJulie E. Strychowsky
Julie E. Strychowsky
RRReza Rahbar
Reza Rahbar
MOMeghan J. O'Hare
Meghan J. O'Hare
AIAlexandria L. Irace
Alexandria L. Irace
HPHoracio Padua
Horacio Padua
CTCameron C. Trenor
Cameron C. Trenor

29 December 2020 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
AIAlexandria L. Irace
Alexandria L. Irace
RSRahul K. Sharma
Rahul K. Sharma
NRNicholas S. Reed
Nicholas S. Reed
JGJustin S. Golub
Justin S. Golub

8 November 2018 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
AIAlexandria L. Irace
Alexandria L. Irace
NDNatasha D. Dombrowski
Natasha D. Dombrowski
KKKosuke Kawai
Kosuke Kawai
PDPamela Dodrill
Pamela Dodrill
JPJennifer Perez
Jennifer Perez
RRReza Rahbar
Reza Rahbar

20 July 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
NDNatasha D. Dombrowski
Natasha D. Dombrowski
NWNikolaus E. Wolter
Nikolaus E. Wolter
CRCaroline D. Robson
Caroline D. Robson
KKKosuke Kawai
Kosuke Kawai
AIAlexandria L. Irace
Alexandria L. Irace
RRReza Rahbar
Reza Rahbar

2 June 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
SSSherif M Shoucri
Sherif M Shoucri
LPLawrence Purpura
Lawrence Purpura
CDClare DeLaurentis
Clare DeLaurentis
MAMatthew Adan
Matthew Adan
DTDeborah A Theodore
Deborah A Theodore
JZJason E Zucker
Jason E Zucker
Objective To characterise the long-term outcomes of patients with COVID-19 admitted to a large New York City medical centre at 3 and 6 months after hospitalisation and describe their healthcare usage, symptoms, morbidity and mortality. Design Retrospective cohort through manual chart review of the electronic medical record. Setting NewYork-Presbyterian/Columbia University Irving Medical Center, a quaternary care academic medical centre in New York City. Participants The first 1190 consecutive patients with symptoms of COVID-19 who presented to the hospital for care between 1 March and 8 April 2020 and tested positive for SARS-CoV-2 on reverse transcriptase PCR assay. Main outcome measures Type and frequency of follow-up encounters, self-reported symptoms, morbidity and mortality at 3 and 6 months after presentation, respectively; patient disposition information prior to admission, at discharge, and at 3 and 6 months after hospital presentation. Results Of the 1190 reviewed patients, 929 survived their initial hospitalisation and 261 died. Among survivors, 570 had follow-up encounters (488 at 3 months and 364 at 6 months). An additional 33 patients died in the follow-up period. In the first 3 months after admission, most encounters were telehealth visits (59%). Cardiopulmonary symptoms (35.7% and 28%), especially dyspnoea (22.1% and 15.9%), were the most common reported symptoms at 3-month and 6-month encounters, respectively. Additionally, a large number of patients reported generalised (26.4%) or neuropsychiatric (24.2%) symptoms 6 months after hospitalisation. Patients with severe COVID-19 were more likely to have reduced mobility, reduced independence or a new dialysis requirement in the 6 months after hospitalisation. Conclusions Patients hospitalised with SARS-CoV-2 infection reported persistent symptoms up to 6 months after diagnosis. These results highlight the long-term morbidity of COVID-19 and its burden on patients and healthcare resources.